Literature DB >> 31900295

Double-hit monomorphic B-cell lymphoma after liver transplantation.

Zabreen Tahir1, Julia Peters1, Kathleen Leahy1, Felipe Batalini2,3.   

Abstract

We report the first case of double-hit (MYC and BCL-6) monomorphic post-transplant lymphoproliferative disorder in a patient status post liver transplantation. Our patient is a 71-year-old man with a past medical history of Budd-Chiari syndrome complicated by cirrhosis and hepatocellular carcinoma. He underwent a deceased donor liver transplantation 2 years prior to presentation and was maintained on tacrolimus and mycophenolate mofetil for immunosuppression. He presented with a 3-week history of classical B-symptoms. Initial workup was notable for elevated lactate dehydrogenase. Abdomen ultrasound revealed multiple hypoechoic lesions, raising suspicion for a post-transplant lymphoproliferative disorder. Biopsy showed pleomorphic large neoplastic cells throughout, consistent with a diagnosis of diffuse large B-cell lymphoma. Cytogenetics then revealed rearrangements in both MYC and BCL-6, consistent with double-hit lymphoma. His immunosuppressive regimen was subsequently tapered and he was started on DA-EPOCH-R (dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab) regimen. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  chemotherapy; haematology (incl blood transfusion); malignant disease and immunosuppression; oncology; transplantation

Mesh:

Substances:

Year:  2020        PMID: 31900295      PMCID: PMC6954779          DOI: 10.1136/bcr-2019-231831

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome.

Authors:  Gianpietro Dotti; Roberto Fiocchi; Teresio Motta; Carmelo Mammana; Eliana Gotti; Silvia Riva; Pieremilio Cornelli; Bruno Gridelli; Piera Viero; Elena Oldani; Paolo Ferrazzi; Giuseppe Remuzzi; Tiziano Barbui; Alessandro Rambaldi
Journal:  Transplantation       Date:  2002-10-27       Impact factor: 4.939

2.  MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.

Authors:  Shaoying Li; Parth Desai; Pei Lin; C Cameron Yin; Guilin Tang; Xuan J Wang; Sergej N Konoplev; Joseph D Khoury; Carlos E Bueso-Ramos; L Jeffrey Medeiros
Journal:  Histopathology       Date:  2015-12-08       Impact factor: 5.087

3.  BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

Authors:  A L Shaffer; X Yu; Y He; J Boldrick; E P Chan; L M Staudt
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

Review 4.  Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.

Authors:  Anna L Taylor; Robert Marcus; J Andrew Bradley
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

Review 5.  The c-Myc target gene network.

Authors:  Chi V Dang; Kathryn A O'Donnell; Karen I Zeller; Tam Nguyen; Rebecca C Osthus; Feng Li
Journal:  Semin Cancer Biol       Date:  2006-07-25       Impact factor: 15.707

6.  Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★).

Authors:  R Reshef; S Vardhanabhuti; M R Luskin; D F Heitjan; D Hadjiliadis; S Goral; K L Krok; L R Goldberg; D L Porter; E A Stadtmauer; D E Tsai
Journal:  Am J Transplant       Date:  2011-01-10       Impact factor: 8.086

Review 7.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

Review 8.  Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.

Authors:  Zeina Al-Mansour; Beverly P Nelson; Andrew M Evens
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

9.  Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant.

Authors:  Bharat Malhotra; Ahmad K Rahal; Hussam Farhoud; Dennis F Moore; K James Kallail
Journal:  Case Rep Transplant       Date:  2015-11-25

Review 10.  Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?

Authors:  J Morscio; D Dierickx; T Tousseyn
Journal:  Clin Dev Immunol       Date:  2013-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.